GIPC Clinical Trials - Medical Students doing research in lab
Jul 21, 2020 - 12:00pm

Innovation Enlisted in the Coronavirus Fight: A State-by-State Analysis

All across the country, America’s innovation community has mobilized like never before to fight the coronavirus pandemic.

Right now, our nation’s brightest scientific minds, most innovative companies, and leading universities are moving at unprecedented speed to deliver the COVID-19 treatments, vaccines, diagnostics, and cures we need.

The scope is as impressive as the speed. To date, scientists have conducted clinical trials of potential COVID-19 solutions in all 50 states, across approximately 85 percent of congressional districts.

Explore the interactive map below to see what kind of COVID-19 research is going on in your community.

 

COVID-19 CLINICAL TRIALS IN THE UNITED STATES

548
 
50

 

The interactive map will not load properly in this browser. Please visit this page with a modern browser. You can also download the data.

 

 

American innovators are doing their part to fight COVID-19. But they can’t do it alone.

They’re relying on legislators to support smart innovation policy – that means maintaining strong intellectual property protections; removing trade barriers, like unnecessary regulations, tariffs, and export bans; and encouraging strategic collaboration through public-private partnership.

With the right innovation policy agenda in place, we’ll help ensure that the medical discoveries happening today can be delivered to patients tomorrow.


Learn More

Each week the U.S. Chamber spotlights companies on the front-line search for effective treatments and vaccines to combat COVID-19, to access the entire catalog of articles, visit the U.S. Chamber Global Innovation Policy Center’s Discover & Deliver page.